UBS lowered the firm’s price target on Blend Labs (BLND) to $3.50 from $4 and keeps a Neutral rating on the shares. Blend continues to face a well-understood challenging mortgage backdrop and focus is shifting towards consumer banking, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLND: